We have previously demonstrated that adult transgenic C57BL/6J mice with CM-restricted overexpression of the dominant negative W v mutant protein (dn-c-kit-Tg) respond to pressure overload with robust cardiomyocyte (CM) cell cycle entry. Here, we tested if outcomes after myocardial infarction (MI) due to coronary artery ligation are improved in this transgenic model. Compared to nontransgenic littermates (NTLs), adult male dn-c-kit-Tg mice displayed CM hypertrophy and concentric left ventricular (LV) hypertrophy in the absence of an increase in workload. Stroke volume and cardiac output were preserved and LV wall stress was markedly lower than that in NTLs, leading to a more energy-efficient heart. In response to MI, infarct size in adult (16-week old) dn-c-kit-Tg hearts was similar to that of NTL after 24 h but was half that in NTL hearts 12 weeks post-MI. Cumulative CM cell cycle entry was only modestly increased in dn-c-kit-Tg hearts. However, dn-c-kit-Tg mice were more resistant to infarct expansion, adverse LV remodelling and contractile dysfunction, and suffered no early death from LV rupture, relative to NTL mice. Thus, pre-existing cardiac hypertrophy lowers wall stress in dn-c-kit-Tg hearts, limits infarct expansion and prevents death from myocardial rupture.
Global functional inactivation (by ~95%) of c-kit (W/Wv mice), the receptor for stem cell factor, prevents the normal developmental acquisition of CM terminal differentiation in the adult animal 1 . At baseline, the cardiac phenotype in W/Wv mice is virtually indistinguishable from that of their congenic wild type littermates. However, when subjected to increased pressure overload, cardiac enlargement in W/Wv mice occurs mainly through CM hyperplasia rather than by CM hypertrophy 1 . Similarly, CM-restricted overexpression of the dominant-negative Wv c-kit mutant protein, c-kitT660M, in mice (dn-c-kit-Tg mice) has no effect on CM proliferation in untreated adult (13- week-old) mice but results in CM cell cycle entry in response to pressure overload, with BrdU + , H3P + and Aurora B + CMs readily apparent in left ventricles one week after pressure overload 1 . Thus, expression of dn-c-kit in CMs after birth is sufficient for pressure overload-induced cell cycle entry of adult CMs 1 .
W/Wv mice are poorly suited for studies of cardiac regeneration post-MI because concomitant inactivation of c-kit on endothelial progenitor cells diminishes the ability of the heart to mount a robust angiogenic response following injurious loss of myocardium 2 . The CM-restricted dn-c-kit-Tg model should, however, lend itself to the study of cardiac regeneration in adult hearts because the heart is composed of CMs that are quiescent at baseline but can be stimulated to proliferate 1 , and the endothelial progenitor cells are unaffected. Here we describe the baseline cardiac phenotype of the dn-c-kit-Tg mouse and show that compared to NTL controls, CM-specific overexpression of dn-c-kit resulted in CM hypertrophy in adulthood. Afterload (left ventricular systolic pressure) was unaltered in this model, indicating the cardiac hypertrophy was primary, and was associated with preserved stroke volume and cardiac output. Moreover, wall stress at baseline was lower in dn-c-kit-Tg mice as a result of increased LV wall thickness and a commensurate decrease in LV chamber diameter, consistent with a more energy-efficient heart. Previous clinical studies have suggested that cardiac hypertrophy is protective of infarct expansion, but it was unclear if the hypertrophy associated with improved outcomes was pre-existing or was the Infarct size after acute MI was equivalent in NTL and dn-c-kit-Tg mice. Clinical studies have suggested that regional wall stress predicts ventricular remodelling and function after MI 7 . We expected that baseline differences in wall stress between genotypes would complicate assessment of post-MI changes in cardiac structure and function independent of potential cardiac regeneration. For this reason, we not only compared the effect of MI in the two genotypes, but examined changes relative to sham controls of each genotype.
We first assessed infarct size after acute permanent coronary artery ligation in NTL and dn-c-kit-Tg hearts. Twenty-four hours post-MI, the LV area at risk was delineated by perfusion with Alcian Blue. This was followed by TTC staining (Fig. 2a ) to quantify the infarcted (or non-viable) tissue area as a percentage of the LV. We found no significant difference between genotypes with respect to LV area at risk as a percentage of the LV (NTL: 20 ± 3, n = 11 vs dn-c-kit-Tg: 22 ± 2, n = 12; p = ns), infarct size/area at risk (NTL: 59 ± 8, n = 11 vs dn-c-kit-Tg: 63 ± 3, n = 12; p = ns) or LV infarct area as a percentage of the LV (Fig. 2b) , indicating that infarct size after acute MI was equivalent between NTL and dn-c-kit-Tg hearts.
Survival was improved, and infarct size was reduced, but CM cell cycle entry was only modestly increased in dn-c-kit-Tg relative to NTL mice after chronic MI. Next, we addressed the long-term impact of MI on cardiac structure and function. NTL and dn-c-kit-Tg mice were subjected to MI or sham surgery and followed for 12 weeks post-surgery. We found no fatalities after MI in dn-c-kit-Tg mice, but ~30% of NTL mice died ( Fig. 2c ). Sham procedures did not result in deaths. NTL deaths mainly resulted from LV rupture within 3-7 days post-MI. At 12 weeks post-MI, infarct sizes in dn-c-kit-Tg hearts were ~50% of NTL sizes (p = 0.02) ( Fig. 2d) .
To assess CM cell cycle entry post-MI, BrdU was infused continuously for 12 weeks, starting immediately after surgery, using implanted osmotic mini-pumps. Cumulative BrdU incorporation into CMs over three months (BrdU + /cTnT + CMs) remained unchanged in NTL mice post-MI (p = ns) but increased by ~two-fold in the hypertrophy of isolated CMs from P121 Tg (682 CMs analysed from n = 3 mice) relative to NTL hearts (1015 CMs analysed from n = 3 mice); differences analysed by Student's t-test. Scale bar: 100 μm. (e) Abundance of Myh6 (encoding α-MHC) and Acta1 (α-skeletal actin) mRNAs was similar, while abundance of other mRNAs (Nppa (ANP), Nppb (BNP), Myh7 (β-MHC)) and the Myh7:Myh6 (β-:α-MHC) ratio were significantly increased in male P196 dn-c-kit-Tg relative to NTL hearts (n = 7); differences analysed by Student's t-test. (f) Increased LV wall thickness to chamber radius (h/r) ratio at end-diastole in P ≥ 196 dn-c-kit-Tg (n = 10-11) relative to NTL (n = 9) hearts; differences analysed by two-way ANOVA with Tukey's multiple comparison test. (g) Increased ejection fraction in P ≥ 196 dn-c-kit-Tg (n = 10-11) relative to NTL (n = 9) hearts; differences analysed by two-way ANOVA with Tukey's multiple comparison test. border zone relative to sham in dn-c-kit-Tg mice (p = 0.02) ( Fig. 3 ). However, given the low percentage of CMs that progressed through mitosis and cytokinesis in adult hearts after nine days of BrdU exposure ( Fig. 1c , Table 3 ), and the observation that this did not lead to changes in nuclear ploidy, nucleation state, or the number of CMs in the heart (Table 3) , it is unlikely that the doubling of the number of CMs that were observed to have entered the cell cycle after three months of continuous BrdU exposure could effect a level of CM replacement that would be sufficient to reduce infarct sizes in dn-c-kit-Tg hearts by ~50% relative to NTL (Fig. 2d ). Staining for neither H3P
Parameter
Genotype P10 (n) P18 (n) P35 (n) P112 (n) P196 (n) P365 (n) BW (g) NTL 4.68 ± 0.11 (9) 8.69 ± 0.28 (5) nor AurB was performed at this chronic time point. There was no evidence of apoptosis three months post-MI in NTL or dn-c-kit-Tg hearts by TUNEL staining ( Supplementary Fig. S3 , Table 5 ).
LV remodelling and infarct expansion was minimal in dn-c-kit-Tg relative to NTL mice after chronic MI.
LV remodelling is a consequence of MI. At 12 weeks post-MI, the LV weight-to-tibial length (LVW/TL) ratio, an index of hypertrophy, increased by 1.3-fold in NTL mice relative to sham controls ( Table 4 , p = 0.002). In contrast, the LVW/TL ratio remained unchanged in dn-c-kit-Tg hearts post-MI, relative to sham controls ( Table 4 , p = ns). Molecular markers of cardiac hypertrophy reflected this difference. In NTL hearts, abundance of Nppa (+5-fold, p = 0.01), Nppb (+2-fold, p = 0.02), Myh7 (+8-fold, p = 0.02) mRNAs and the Myh7:Myh6 ratio (+27-fold, p = 0.03) ( Fig. 2e ) as well as abundance of β-MHC protein ( Fig. 2f ) increased post-MI. In dn-c-kit-Tg hearts, the abundance of these markers was unaltered post-MI ( Fig. 2e ). The size of the MIs produced by the coronary artery ligation procedure was not sufficiently large to induce heart failure in NTL or dn-c-kit-Tg mice post-MI. This is reflected by the findings that in both genotypes right ventricular weights and lung weights were not significantly increased relative to their respective shams (Table 4) , nor were levels of fibrosis in regions remote to the infarct (Table 5 ). While loss of c-kit function in endothelial c-kit+ stem cells causes defective myocardial angiogenesis 2 , we found no significant difference between NTL and dn-c-kit-Tg hearts in capillary density, CM-to-capillary ratio or mean inter-capillary distance in the area remote from the infarct (Table 5 ). Thus, CM-restricted overexpression of dn-c-kit did not impact coronary architecture.
LV chamber dilatation, a feature of post-MI cardiac remodelling is the principle cause of infarct expansion 7 . LV chamber dilatation was observed in both genotypes, but it was more marked in NTL hearts post-MI. This was evident from changes in i) LV internal chamber radius [NTL hearts: +30 (p = 0.03), +35 (p = 0.005), +57 (p < 0.0001), +109% (p < 0.0001) post-MI compared to sham controls at the mid papillary level and 1, 2 and 3 mm distal, respectively, versus dn-c-kit-Tg hearts: +36% (p = 0.01) post-MI compared to sham controls at 3 mm distal to the mid-papillary level], ii) LV end-diastolic volume (LVEDV) [NTL hearts: +2.54-fold post-MI compared to their sham controls, p = 0.0001, versus dn-c-kit-Tg hearts: no significant difference post-MI compared to their sham controls], and iii) tissue area in short-axis (SAX) view [NTL hearts: +1.3 (p = 0.002), +1.3 (p = 0.022), +1.5 (p = 0.005), +1.9 (p = 0.002) post-MI compared to their sham controls versus dn-c-kit-Tg hearts: no significant difference post-MI compared to their sham controls] ( Table 4 ). As noted above, LV infarct area, as a percentage of LV area, in dn-c-kit-Tg hearts was about half that of NTL mice (Fig. 2d ), and was no greater 12 weeks post-MI than 24 h post-MI, whereas in NTL mice, infarct area 12 weeks post-MI was ~two-fold greater than 24 h post-MI. This is likely due to greater infarct expansion and LV wall thinning of infarcts in NTL than in dn-c-kit-Tg hearts. Thus, our findings indicate a lack of post-MI infarct expansion in dn-c-kit-Tg hearts.
Cardiac function was preserved in dn-c-kit-Tg mice relative to NTL mice after chronic MI.
We also assessed cardiac functional consequences of MI in NTL and dn-c-kit-Tg mice. Compared to their respective shams, the LV ejection fraction (LVEF) post-MI ( Fig. 4a , Table 4 ) decreased by almost half in NTL mice from 72% to 38% (p < 0.0001), but only by a third in dn-c-kit-Tg hearts from 87% to 61% (p < 0.0001). Differences between the genotypes in regional contractile function, indexed by the fractional area change between end-diastole and end-systole, were less pronounced. Thus, compared with their respective sham controls at the mid papillary level and 1, 2 and 3 mm distal, fractional area change decreased by −35 (p = 0.03), −51 (p = 0.0003), −48 (p = 0.004) and −69% (p < 0.0001), respectively, in NTL hearts post-MI versus 0 (p = ns), −29 (p = 0.0024), −47 (p < 0.0001), −48% (p < 0.0001), respectively, in dn-c-kit-Tg hearts ( Table 4 ). LV stroke volume and cardiac
No. of CMs/heart 2.2 × 10 6 ± 1 × 10 5 (7) 2.1 × 10 6 ± 3 × 10 4 (9) output were similar in NTL sham and dn-c-kit-Tg sham mice, and remained unaltered post-MI (Table 4 , p = ns). The single beat preload recruitable stroke work (PRSW) slope, a load-independent index of cardiac performance 8 , indicated that contractility of dn-c-kit-Tg sham hearts was 1.3-fold higher than in NTL sham hearts before MI (p = 0.009; Fig. 4b , Table 4 ). Post-MI, the PRSW slope in NTL hearts was reduced to almost half of that in sham controls (p = 0.007; Fig. 4b , Table 4 ) whereas in dn-c-kit-Tg hearts the reduction in PRSW slope was markedly less, with the post-MI PRSW slope being ~70% of that of their sham controls (p < 0.0001; Fig. 4b , Table 4 ). Thus, although the PRSW slope fell post-MI in both genotypes, it was better maintained in dn-c-kit-Tg hearts (−31.3%) than in NTL hearts (−47%). Better preservation of myocardial contractility in dn-c-kit-Tg mice was also evident from another load-independent index: LV dP/dt max normalized to EDV 9 , which was 1.8-fold higher in dn-c-kit-Tg relative to NTL hearts, both in sham (p = 0.008) and in post-MI groups (p = 0.02, Fig. 4c ). Indices of diastolic LV function also differed between the genotypes post-MI. In NTL hearts, LV dP/dt min , fell post-MI (sham: −9132 ± 609 n = 8, MI: −6844 ± 699 mmHg/s n = 11; p = 0.03) and Tau, a preload-independent measure of isovolumic relaxation, increased 1.9-fold (sham: 11 ± 0.3 n = 8, MI: 21 ± 4 ms n = 11; p = 0.04). In contrast, both of these indices remained unchanged post-MI in dn-c-kit-Tg hearts (dP/dt min : Sham, −8795 ± 902 n = 15; MI, −7542 ± 306 mmHg/s n = 16; p = ns. Tau: Sham, 15 ± 3 n = 15; MI, 14 ± 1 ms n = 16; p = ns).
Discussion
Primary cardiac hypertrophy is the major phenotype of clinical forms of hypertrophic cardiomyopathy that are associated with mutations in the sarcomeric genes, including myosin-binding protein C, β-myosin heavy chain and cardiac troponin T 10 . This is manifested by increased cardiomyocyte size; myofibrillar disarray; altered LV geometry, including diminished LV chamber diameter; myocardial fibrosis; enhanced expression of fetal genes encoding atrial (Nppa) and brain (Nppb) natriuretic factor, α-myosin heavy chain (Myh6, or in rodents, Mhy7) and α-skeletal actin (Acta1); and an altered myocardial vasculature 6, [11] [12] [13] [14] . However, even amongst patients with the same mutation, there is considerable variation in symptoms and severity with clinical manifestations ranging from benign to severe heart failure and sudden death 12, 15, 16 . These hallmarks of hypertrophy are also observed in mouse models of hypertrophic cardiomoyopathy 6, 17 . The primacy of the genetic change as the underlying cause of CM enlargement in these mouse models is the lack of hypertension or other factors that would stimulate hypertrophy by increasing afterload. Many of these phenotypic changes were observed basally in the dn-c-kit-Tg model, including LV hypertrophy (increased LVW/TL ratio, increased LVED wall thickness) with decreased LV cavity size (decreased LV internal chamber radius) and CM hypertrophy (increased CM area) in the absence of an increase in afterload (LVSP unchanged) as well as activation of the fetal gene program (enhanced Nppa, Nppb and Myh7 mRNA levels). Hence, dn-c-kit-Tg mice display the hallmarks of primary concentric cardiac hypertrophy.
Although activation of the fetal gene program is generally observed in pathological forms of hypertrophy, it is of interest that in the dn-c-kit-Tg hearts, hypertrophy occurred in the absence of other markers of pathological hypertrophy, such as decreased Myh6 expression and increased Acta1 expression, myofibrillar disarray, increased myocardial fibrosis, altered capillary density or increased apoptosis. Moreover, because both end-systolic and end-diastolic chamber volumes were reduced commensurately in dn-c-kit-Tg hearts, stroke volume and cardiac output were maintained. The most important consequence of this altered LV geometry was that end-systolic and end-diastolic wall stresses were markedly lower in dn-c-ki-Tg hearts than in age-matched NTL hearts and, as a result, LV triple product was lower in dn-c-kit-Tg hearts. Thus, despite frank concentric hypertrophy, these features of dn-c-kit-Tg hearts provide a unique opportunity to evaluate factors that might contribute to variations in severity of hypertrophic cardiomyopathies and that might also mitigate sequelae post-MI. After MI, infarct size increases by extension and expansion; the latter being an important risk factor for death by LV wall rupture or aneurysm formation 7 . Infarct extension is the product of apoptotic and necrotic cell death. We show here that coronary artery ligation in dn-c-kit-Tg and WT hearts produced equivalent infarct sizes at 24 hours post-MI. This finding suggests that neither cardiac cell survival nor apoptosis were significantly altered by dn-c-kit expression in CMs. Infarct expansion is mainly due to LV wall thinning and chamber dilatation, which leads to increased wall stress 7 . Analysis of 12 week post-MI hearts indicated markedly expanded infarcts in NTL but not in dn-c-kit-Tg hearts. In keeping with this, remodelling of the LV of dn-c-kit-Tg hearts was much less 1.0 ± 0.03 (9) 0.9 ± 0.03 (9) 0.8 ± 0.05 (9)
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3.1 ± 0.2*** (9) than that of NTLs after MI. These findings are entirely consistent with clinical studies based on autopsy findings, which indicate that infarct expansion is less marked in hearts with ventricular hypertrophy 3 , whereas increased wall stress is a stimulus for cardiac hypertrophy 18, 19 and predicts both ventricular remodelling and impaired function after MI 7 . However, it was unclear from these clinical studies if the hypertrophy observed post-mortem was pre-existing or due to remodelling of non-infarcted myocardium. The finding that infarct expansion occurs more commonly with infarcts involving the left anterior descending coronary artery distribution, a region of the LV with the greatest curvature, has been suggested to indicate that the degree to which an infarct expands may be influenced by the pre-infarct thickness of the ventricular wall 3 . In that study 3 , it was not possible to exclude the possibility that protection from infarct expansion was due to the infarcts being smaller in the hypertrophic heart. The finding that infarct size remained unchanged in dn-c-kit-Tg hearts, which have pre-existing hypertrophy with reduced LV wall stress and improved energetics, therefore, strongly supports the notion that pre-infarct hypertrophy limits infarct expansion. Moreover, lower wall stress and attenuated infarct expansion reduce the risk of LV wall rupture 7 , which likely explains the improved survival of dn-c-kit-Tg mice post-MI, with most deaths in the NTL mice occurring 3-7 days post-MI due to ventricular rupture. While c-kit inactivation in CMs can cause CMs to retain proliferative competence, as we have shown previously using a pressure-overload model 9 , in the current study we found that MI did not trigger meaningful increases in CM cell cycle entry in the infarct border zone of dn-c-kit-Tg hearts. Both preload and afterload are increased in left ventricles post-MI 20 . But unlike increased ventricular afterload due to aortic constriction 9 , MI also reduces the CM population in the infarct zone, and the load-increase in the border zone and remote zones is modest when compared with the load imposed by aortic constriction. This is particularly the case in dn-c-kit-Tg mice because wall stress prior to MI was markedly lower and LV dilatation post-MI was much reduced, relative to NTL mice. In addition, effective cardiac regeneration requires simultaneous resorption of the post-infarct scar tissue as well as robust CM proliferation to achieve complete repair of the myocardium, as observed in the regenerating adult zebrafish heart 21 and the neonatal murine heart 22 . Systemic and local immune responses play critical roles in scar formation and resorption 23 . In neonatal hearts the acute inflammatory response stimulates the regenerative response 24 , but in adults it accelerates infarct progression. It is possible that an aggressive post-MI inflammatory response in adulthood attenuates pro-proliferative signals caused by injury. Future studies should help in understanding the role of inflammatory mediators, which are activated early after MI injury, in the cardiac regenerative process in adults. Mice. Heterozygous α-MHC/W v -Tg-2.1 mice (designated here as dn-c-kit-Tg), with cardiac-restricted overexpression of the dominant-negative c-kit Wv (T660M) mutant protein, were generated on a pure C57BL/6J background as described 1 . Heterozygous dn-c-kit-Tg and NTL generated from dn-c-kit-Tg × NTL crosses were used.
Methods

Ethics
Adult CM isolation. CMs were isolated from male mice from litters of 6-8 in size. Hearts were excised and perfused as described 25 with the following modification: perfusion buffer contained 3 mg/mL collagenase (Worthington) for 8 min at 37 °C. For downstream immunocytochemistry, area measurement and determination of nucleation status, hearts were perfused with 2 mL freshly thawed 2% PFA before disaggregation; for downstream CM counting and ploidy determination, hearts were not fixed. Hearts were gently disaggregated by teasing apart the tissue with forceps for 5 mins in a petri dish before passaging through transfer pipettes of progressively smaller diameters. Dissociated PFA-fixed cells were diluted to 15 mL with PBS and washed (2 × 5 mins, 168 g) to remove PFA.
Immunocytochemistry of isolated CMs. To enable evaluation of CMs undergoing cell cycle entry (BrdU), metaphase (phospho-histone H3, H3P) or anaphase (Aurora kinase B, AurB), osmotic mini-pumps (Alzet Model 2002) were implanted subcutaneously into the flank of male mice (16 weeks old, n = 4) to deliver 5-bromo-2′-deoxyuridine (BrdU, 25 mg/mL in 50% DMSO/water to deliver 10 mg/kg/day) for nine days. Briefly, PFA-fixed CMs were cytospun onto Superfrost slides, and fixed again (2% PFA, 5 mins, RT). Slides were washed with 0.1 M glycine to quench any unreacted aldehyde. For heat-induced antigen retrieval, slides were incubated (96 °C, 5 mins) in sodium citrate buffer and allowed to cool in the buffer for 1 h. For AurB staining, endogenous peroxidases were quenched (0.3% (v/v) H 2 O 2 in 70% (v/v) methanol in PBS, 30 min, RT, rocking). All slides were blocked and permeabilized for 1 h (for BrdU or H3P staining: 5% (v/v) normal donkey serum, 0.2% PBS-Triton X-100 (PBS-T); for AurB staining: 3% (v/v) normal donkey serum, 3% BSA (v/v), 0.1% PBS-T) before incubating overnight at 4 °C with primary mouse anti-cTnT monoclonal antibody (Abcam, ab10214, 1:600) and rat anti-BrdU monoclonal antibody (Abcam, ab 6326, 1:100), rabbit anti-H3P polyclonal antibody (Abcam, ab5176, 1:60) or rabbit anti-AurB polyclonal antibody (Abcam, ab2254, 1:50). Slides were then incubated for 1 h at RT with species-appropriate secondary donkey anti-mouse-488 (Jackson laboratory, 715-545-151, 1:500) and donkey anti-rat-RRX (Jackson laboratory, 712-295-153, 1:500 in 5% (v/v) normal donkey serum, 0.01% PBS-T), donkey anti-rabbit-RRX (for H3P, Jackson laboratory, 711-295-152, 1:500 in 5% (v/v) normal donkey serum, 0.01% PBS-T) or donkey anti-rabbit-biotin (for AurB, Jackson laboratory, 711-065-152, 1:250 in 1% (v/v) BSA in PBS).
For AurB staining, slides were incubated with ABC complex (VECTASTAIN ® Elite ® ABC-HRP kit, PK-6101) for 1 h at RT, then with Tyramide-cys3 (TSA Cyanine 3 system, NEL704A001KT, 1:100) for 3 min. Nuclei were SCiEntifiC REpoRtS | (2018) 8:6114 | DOI:10.1038/s41598-018-24525-6 stained with 4′,6-diamidino-2-phenylindole (DAPI, Sigma Aldrich, D9542) before mounting coverslips. cTnt + / BrdU + , cTnt + /H3P + or cTnt + /AurB + CMs were counted under the confocal microscope (Zeiss LSM 700 Upright, MicroImaging GmbH, 07740 Jena, Germany) and representative images taken. CMs isolated from two-day old (P2) hearts were used as controls for H3P and AurB antibody staining.
Area measurement and nucleation status of isolated CMs. PFA-fixed CMs were cytospun onto Superfrost slides, blocked with 5% (v/v) normal donkey serum (1 h), incubated with primary mouse anti-cTnT monoclonal antibody (Abcam, ab 10214, 1:600, overnight, 4 °C), then secondary antibody donkey anti-mouse-488 (Jackson laboratory, 715-545-151, 1:500, 1 h, RT). Nuclei were stained with TO-PRO TM -3 Iodide (642/661) (Invitrogen, T3605) before mounting coverslips. CM surface area was calculated from 100 fields (20x objective, Zeiss LSM 7 DUO, tiling function, MicroImaging GmbH, 07740 Jena, Germany) using ImageJ. CM nucleation was calculated using the cell counter plugin (https://imagej.nih.gov/ij/plugins/cell-counter.html).
Counting and ploidy determination of isolated CMs. CMs were counted on a haemocytometer in Transfer Buffer A 25 . After counting, CMs were fixed in ice-cold 70% v/v ethanol. Nuclei were liberated by digestion with 0.2 M HCl and 1 mg/mL pepsin (37 °C, 15 min) 26 and pelleted. Nuclei were stained with 50 μg/mL propidium iodide with 12 μg/mL RNase (22 °C, 30 min) and analysed using a Canto II flow cytometer (BD). At least 30,000 nuclei were analysed per heart. P4 CMs, which are in majority diploid, were used as ploidy control. TUNEL staining. Apoptosis in heart sections was detected by In Situ Cell Death Detection Kit, TMR red (Roche) according to manufacturer's instructions.
Myocardial infarction and infarct size determination.
Male mice (16 weeks old) were randomised, anaesthetised (ketamine: 100 mg/kg, xylazine: 13 mg/kg, atropine: 0.5 mg/kg) by intraperitoneal injection, placed on a heating pad, intubated and ventilated (120 breaths/min). Depth of anaesthesia was monitored by respiration rate, colour of mucous membranes and skin, and toe pinch reflex. The heart was accessed by an incision of the left wall of the chest at the fourth intercostal space. Mice were subjected to myocardial infarction (MI) by permanent ligation of the left anterior descending coronary artery (8/0 prolene suture) at about 2 mm below the edge of the left auricle, or to sham operation. The chest was closed and the pneumothorax reduced. Mice were monitored continuously during recovery until the righting reflex was regained, and housed overnight half on a heating pad. Post-operative analgesia (buprenorphine, 0.075 mg/kg) was administered subcutaneously twice daily for three days. To cumulatively label cells entering S phase, an osmotic mini-pump (Alzet Model 2006) was implanted subcutaneously into the flank immediately after surgery to deliver BrdU (83 mg/mL in 50% DMSO/water; 10 mg/ kg/day for 6 weeks) and replaced 6 weeks post-surgery under isoflurane (1-2%) anaesthesia, with post-operative analgesia (bupivacaine, 8 mg/kg) administered subcutaneously at the wound site for three days after surgery.
Infarct size was determined at 24 h post-MI by planimetry of infarcted tissue in 1 mm thick LV coronal slices (mouse heart slicer matrix, Zivic Instruments) following perfusion with 0.02% Alcian-blue, staining with 2,3,5-triphenyltetrazolium chloride (1% in phosphate-buffered saline) and fixation (10% formalin solution in neutral buffer) as described 27 . To measure infarct size 12 weeks post-MI, the heart was excised immediately following hemodynamic measurements, atria and right ventricle were trimmed off, the LV was cut open and pinned flat to expose the endocardial surface for determination by planimetry of LV wall scar tissue as a percentage of the total LV chamber area 28 . LV tissue was cut parasagitally into thirds so that each piece contained a portion of infarcted tissue. One piece was processed for paraffin-embedding and two pieces were snap-frozen in liquid nitrogen for quantitative RT-PCR and protein analyses.
Echocardiography. Echocardiography was performed on isoflurane-anaesthetized mice (~1-2%) using a Vevo 770 cardiac ultrasound system (VisualSonics) on a heating pad. After shaving the chest and washing with 70% ethanol, ultrasound gel was applied to the chest wall and B-mode images were taken of LV long axis (LAX) followed by four short axis (SAX) views at the mid-papillary level, and then at the levels 1, 2 and 3 mm toward the apex. LV length was measured from the apical dimple to the base of the aortic valve leaflets from the LAX images at end-diastole and end-systole. The areas boarded by the endo-and epicardium were determined by planimetry of all four SAX images at end-diastole and end-systole, and from this a modified Bullet formula was applied to derive LVED and LVES volumes (LV vol = L × (mean endocardial area) × 5/6). In addition, tissue cross-sectional area (CSA) and fractional area change (FAC) for each SAX image were calculated. Tissue CSA was calculated as the difference between the epicardial CSA and the endocardial CSA at end-diastole. FAC was calculated as the difference between the end-diastolic and end-systolic endocardial CSA divided by the end-diastolic endocardial CSA, and expressed as a percentage. Mean chamber radius (r = √(endocardial area/π) and wall thickness (h = √(epicardial area/π) -r) were calculated from the end-diastolic CSA data. The acquisition of images and evaluation of data were performed by an operator who was blinded to the genotype and treatment of the mice.
Hemodynamic Measurements. Hemodynamic measurements were performed on isoflurane-anaesthetized (~1-2%) mice using a 1.2 F micromanometer transducer tipped catheter (Scisense Inc, Toronto, CA) that was passed via the right carotid artery into the aorta (for measurement of central arterial pressure) and then advanced into the LV of the heart. LV pressure and heart rate were monitored until stable recordings were obtained at a heart rate of ~500 bpm. Immediately following hemodynamic measurements, anaesthetized mice were euthanised by cervical dislocation and hearts were collected for analysis.
Quantitative RT-PCR. RNA isolated from a third of a snap-frozen LV was subjected to RT-qPCR as described 29 .
Using the 2 −ΔΔCT method, relative expression (fold change) of c-kit (Kit, TaqMan assay ID: Mm00445212_m1, amplicon length 71 bp spanning exons 7-8, context sequence: 5′-TTTACGTGAACACAAAACCAGAAAT-3′ with
